Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0373 Transporter Info | ||||
Gene Name | SLC46A2 | ||||
Transporter Name | Thymic stromal cotransporter homolog | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Prostate cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in prostate cancer | [ 1 ] | |||
Location |
5'UTR (cg15936066) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.16E+00 | Statistic Test | p-value: 1.31E-03; Z-score: 5.41E+00 | ||
Methylation in Case |
6.68E-01 (Median) | Methylation in Control | 3.10E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg14253875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 4.31E-02; Z-score: 1.30E+00 | ||
Methylation in Case |
8.84E-01 (Median) | Methylation in Control | 8.68E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg14004271) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 9.62E-05; Z-score: -4.56E+00 | ||
Methylation in Case |
8.04E-01 (Median) | Methylation in Control | 9.06E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg00238426) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 8.96E-03; Z-score: -1.20E+00 | ||
Methylation in Case |
8.34E-01 (Median) | Methylation in Control | 8.57E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg10726357) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.49E-02; Z-score: 6.99E-01 | ||
Methylation in Case |
6.30E-01 (Median) | Methylation in Control | 5.96E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A2 in breast cancer | [ 3 ] | |||
Location |
1stExon (cg07758904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 1.01E-02; Z-score: 4.72E-01 | ||
Methylation in Case |
1.35E-01 (Median) | Methylation in Control | 1.11E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A2 in breast cancer | [ 3 ] | |||
Location |
Body (cg14004271) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 8.04E-03; Z-score: -3.90E-01 | ||
Methylation in Case |
9.29E-01 (Median) | Methylation in Control | 9.47E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg10726357) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 3.37E-06; Z-score: -1.77E+00 | ||
Methylation in Case |
8.47E-01 (Median) | Methylation in Control | 8.93E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A2 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg14253875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 4.51E-02; Z-score: -9.20E-01 | ||
Methylation in Case |
9.75E-01 (Median) | Methylation in Control | 9.79E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A2 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg11724516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 2.45E-02; Z-score: 5.17E-01 | ||
Methylation in Case |
1.61E-02 (Median) | Methylation in Control | 1.34E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A2 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
1stExon (cg07758904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.47E+00 | Statistic Test | p-value: 2.94E-03; Z-score: 5.48E-01 | ||
Methylation in Case |
1.27E-01 (Median) | Methylation in Control | 8.67E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS1500 (cg02573176) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.45E+00 | Statistic Test | p-value: 3.09E-06; Z-score: -2.23E+00 | ||
Methylation in Case |
3.54E-01 (Median) | Methylation in Control | 5.12E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A2 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg17383222) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 4.82E-04; Z-score: -2.32E+00 | ||
Methylation in Case |
7.41E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A2 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg03861217) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 3.52E-03; Z-score: -1.83E+00 | ||
Methylation in Case |
6.22E-01 (Median) | Methylation in Control | 7.02E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg10726357) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 1.49E-05; Z-score: 1.35E+00 | ||
Methylation in Case |
8.70E-01 (Median) | Methylation in Control | 8.09E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A2 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg14253875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 4.90E-03; Z-score: 7.44E-01 | ||
Methylation in Case |
9.43E-01 (Median) | Methylation in Control | 9.34E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A2 in colorectal cancer | [ 6 ] | |||
Location |
TSS200 (cg11724516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.84E+00 | Statistic Test | p-value: 1.40E-13; Z-score: 9.04E+00 | ||
Methylation in Case |
4.86E-01 (Median) | Methylation in Control | 1.00E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A2 in colorectal cancer | [ 6 ] | |||
Location |
1stExon (cg07758904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.75E+00 | Statistic Test | p-value: 2.72E-10; Z-score: 2.50E+00 | ||
Methylation in Case |
7.62E-01 (Median) | Methylation in Control | 4.35E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg14253875) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 6.00E-04; Z-score: -8.22E-01 | ||
Methylation in Case |
8.65E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A2 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS200 (cg11724516) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 7.21E-06; Z-score: 6.82E-01 | ||
Methylation in Case |
7.70E-02 (Median) | Methylation in Control | 6.55E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A2 in hepatocellular carcinoma | [ 7 ] | |||
Location |
1stExon (cg07758904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.92E+00 | Statistic Test | p-value: 4.17E-08; Z-score: 2.34E+00 | ||
Methylation in Case |
3.55E-01 (Median) | Methylation in Control | 1.85E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A2 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg01082559) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 1.38E-11; Z-score: -2.95E+00 | ||
Methylation in Case |
6.10E-01 (Median) | Methylation in Control | 7.92E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC46A2 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg14004271) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.24E-05; Z-score: -8.77E-01 | ||
Methylation in Case |
9.07E-01 (Median) | Methylation in Control | 9.38E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC46A2 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg00238426) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.13E-03; Z-score: -3.79E-01 | ||
Methylation in Case |
8.36E-01 (Median) | Methylation in Control | 8.45E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC46A2 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg13696535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.89E-02; Z-score: -1.58E-01 | ||
Methylation in Case |
8.74E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC46A2 in hepatocellular carcinoma | [ 7 ] | |||
Location |
3'UTR (cg19728345) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.81E+00 | Statistic Test | p-value: 2.26E-22; Z-score: -4.52E+00 | ||
Methylation in Case |
2.05E-01 (Median) | Methylation in Control | 5.77E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in lung adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg10726357) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 1.63E-03; Z-score: 2.25E+00 | ||
Methylation in Case |
7.28E-01 (Median) | Methylation in Control | 6.56E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A2 in lung adenocarcinoma | [ 8 ] | |||
Location |
1stExon (cg07758904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.79E+00 | Statistic Test | p-value: 2.91E-02; Z-score: 3.30E+00 | ||
Methylation in Case |
3.42E-01 (Median) | Methylation in Control | 1.90E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg00961932) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 3.86E-03; Z-score: -7.95E-01 | ||
Methylation in Case |
1.79E-01 (Median) | Methylation in Control | 2.18E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A2 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS200 (cg11940663) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 2.07E-03; Z-score: -9.27E-01 | ||
Methylation in Case |
5.49E-02 (Median) | Methylation in Control | 6.25E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A2 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg09887627) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 1.57E-03; Z-score: 7.10E-01 | ||
Methylation in Case |
8.87E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in panic disorder | [ 10 ] | |||
Location |
TSS1500 (cg10726357) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 4.98E-02; Z-score: -4.91E-01 | ||
Methylation in Case |
5.76E-01 (Median) | Methylation in Control | 7.50E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A2 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg10726357) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 7.83E-13; Z-score: 2.24E+00 | ||
Methylation in Case |
8.44E-01 (Median) | Methylation in Control | 7.61E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC46A2 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 5.68E-13; Fold-change: 0.455610443; Z-score: 6.260820922 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
microRNA |
|||||
Unclear Phenotype |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-335 directly targets SLC46A2 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-335 | miRNA Mature ID | miR-335-5p | ||
miRNA Sequence |
UCAAGAGCAAUAACGAAAAAUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.